Health and Fitness Health and Fitness
Tue, March 3, 2009
[ 04:12 PM ] - Market Wire
XELR8 Holdings, Inc.: XELR8 Holdings Loses Appeal at the NYSE Alternext
[ 01:01 PM ] - Market Wire
Myriad Genetics: Myriad Genetics to Present at Cowen Health Care Conference on March 17, 2009
[ 06:11 AM ] - Market Wire
Anaconda Mining Inc.: Anaconda Announces Initiati .. of Arbitration Process With JV Partner New Island
[ 05:30 AM ] - Market Wire
CV Therapeutics, Inc.: Ranexa(R) Now Available in United Kingdom and Germany
[ 05:30 AM ] - Market Wire
Given Imaging: Given Imaging Sets Dividend Distribution Date
[ 05:00 AM ] - Market Wire
X PRIZE Foundation: X PRIZE Foundation, WellPoint .. Hold Advisory Summit to Propose Ideas for Health
[ 04:30 AM ] - Market Wire
FONAR Corporation: FONAR Enters Africa and Middle .. kets With Sale to Leading Medical Center in Libya
[ 03:30 AM ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Reports .. Results for the Fourth Quarter and Year-End 2008
Mon, March 2, 2009
[ 05:00 PM ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Submits .. for XIAFLEX(TM) for the Treatment of Dupuytren's
[ 02:30 PM ] - Market Wire
Constellation Software Inc.: Midwest Energy Inc. .. ary of Constellation Software's Harris Subsidiary
[ 01:30 PM ] - Market Wire
Sun Healthcare Group, Inc.: Sun Healthcare Group, .. Earnings; Strong Results Led by Growth in Skilled
[ 01:25 PM ] - Market Wire
Wellstar International, Inc.: Wellstar/TMI to Uti .. Board Members in the Marketing of Imaging Systems
[ 01:01 PM ] - Market Wire
PDL BioPharma: PDL BioPharma Announces Fourth Quarter and Full Year 2008 Financial Results
[ 10:50 AM ] - Market Wire
NeuroInvestment: Migraine Therapeutics Reviewed by NeuroInvestment
[ 05:30 AM ] - Market Wire
Hansen Medical, Inc.: Hansen Medical Announces St .. anced Cardiac Therapeutics and Procurement of Cer
[ 05:00 AM ] - Market Wire
Pentaho Corporation: Cardiac Science Selects Pentaho to Streamline Information Integration
[ 05:00 AM ] - Market Wire
Watson Pharmaceuticals: Watson to Present at Barclays Capital Global Healthcare Conference
[ 04:30 AM ] - Market Wire
Targeted Genetics: Targeted Genetics Provides Business Update and Announces Extended Cash Horizon
Fri, February 27, 2009
[ 03:00 PM ] - Market Wire
Response Genetics Announces $2 Million Private Placement
[ 01:05 PM ] - Market Wire
Proton Laboratories Inc.: Proton Laboratories Signs $18,500,000 Advertising Deal
[ 01:00 PM ] - Market Wire
Rexahn Pharmaceuticals Receives Notice from NYSE Alternext US LLC
[ 12:30 PM ] - Market Wire
Tenet Healthcare Corporation Announces Completion of Exchange Offer
[ 12:30 PM ] - Market Wire
Nanobac Pharmaceuticals: Nanobac Message to Shareholders
[ 09:41 AM ] - Market Wire
Amador Gold Corp.: Amador Drills Gold and Nickel-Copper Targets at Loveland Project
[ 07:17 AM ] - Market Wire
Schaeffer's Street Stories: AstraZeneca plc Plunges on FDA Concerns Regarding Seroquel Approval
[ 06:24 AM ] - Market Wire
UnitedHealth Group to Open New Service Center in Harlingen, Texas
[ 06:00 AM ] - Market Wire
Edwards Lifesciences : Edwards Lifesciences' Chai .. nd CEO Revises Existing 10b5-1 Stock Trading Plan
[ 05:58 AM ] - Market Wire
Healthways Participates in New NCQA Wellness & Health Promotion Accreditation Program
[ 05:15 AM ] - Market Wire
Cougar Biotechnology Announces Presentation of Po .. etate) Phase II Data at ASCO 2009 Genitourinary C
[ 05:00 AM ] - Market Wire
Trinity Biotech: Trinity Biotech plc to Announce Year End Results

Trinity Biotech: Trinity Biotech plc to Announce Year End Results


Published on 2009-02-27 05:23:07, Last Modified on 2009-02-27 05:23:30 - Market Wire
  Print publication without navigation


DUBLIN, IRELAND--(Marketwire - February 27, 2009) - Trinity Biotech plc (NASDAQ: [ TRIB ]), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will release 2008 year end results on Tuesday, 10th March, 2009.

The Trinity Biotech Management team will discuss year end financial performance with investors and analysts on a conference call scheduled for 12.00 noon ET (4:00 pm GMT) on that date.

Dial-in details to follow.

[ www.trinitybiotech.com ].

Contributing Sources